Each cardiovascular procedure provides unique challenges that can cause complications for the healing process. Here are a few examples:
Coronary Artery Bypass Graft (CABG)
In CABG surgeries, haemostats ensure the surgical field is visible and bleeding risks are minimised to optimise postoperative recovery. FLOSEAL, Baxter's flowable haemostat, actively achieves haemostasis quickly (2 min median time to haemostasis)1 leading to improved clinical outcomes2 and reduced annual cost of care3.
Aortic Aneurysm Repair
During an aortic aneurysm repair, synthetic sealants can work independently of the coagulation cascade to prevent bleeding4,5. COSEAL, Baxter's fully synthetic sealant, provides a thin, translucent, motion-responsive seal that supports natural vascular dilation and can be sutured through, while allowing for visibility at the suture line6.
Valve replacements or repairs
Valve replacement and repair surgeries, like other major CV procedures, often come with a higher risk of bleeding. TISSEEL fibrin sealant can be used to control diffuse bleeding, such as on the epicardial surface, and is effective in fully heparinised patients undergoing cardiopulmonary bypass.
Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse Event and Product Complaint Handling
Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44) 01635 260360
Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 1604 704603).